Literature DB >> 23402459

Coronary artery disease.

Michele A Hanson1, Mohammad Tariq Fareed, Sandra L Argenio, Akochi O Agunwamba, Teresa R Hanson.   

Abstract

Coronary artery disease (CAD) is the leading cause of death worldwide. There are several presenting clinical syndromes, including sudden cardiac death. Risk factor analysis can help the primary care provider identify patients who may need more extensive evaluation or treatment. Treatment may be medical or surgical and depends on the individual patient's comorbidities and preferences. In the future, growth of new blood vessels or cardiac cells may aid in the treatment of CAD.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23402459     DOI: 10.1016/j.pop.2012.12.001

Source DB:  PubMed          Journal:  Prim Care        ISSN: 0095-4543            Impact factor:   2.907


  15 in total

1.  MicroRNA-322 protects hypoxia-induced apoptosis in cardiomyocytes via BDNF gene.

Authors:  Liguo Yang; Shigang Song; Hang Lv
Journal:  Am J Transl Res       Date:  2016-06-15       Impact factor: 4.060

2.  Short-Term Adjuvant Therapy with Terminalia arjuna Attenuates Ongoing Inflammation and Immune Imbalance in Patients with Stable Coronary Artery Disease: In Vitro and In Vivo Evidence.

Authors:  Divya Kapoor; Dimple Trikha; Rajesh Vijayvergiya; K K Parashar; Deepak Kaul; Veena Dhawan
Journal:  J Cardiovasc Transl Res       Date:  2015-04-01       Impact factor: 4.132

3.  Sinomenine Confers Protection Against Myocardial Ischemia Reperfusion Injury by Preventing Oxidative Stress, Cellular Apoptosis, and Inflammation.

Authors:  Boyu Xia; Qi Li; Jingjing Wu; Xiaomei Yuan; Fei Wang; Xu Lu; Chao Huang; Koulong Zheng; Rongrong Yang; Le Yin; Kun Liu; Qingsheng You
Journal:  Front Pharmacol       Date:  2022-06-28       Impact factor: 5.988

4.  Interferon-gamma increases the ratio of matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 in peripheral monocytes from patients with coronary artery disease.

Authors:  Rashidi Springall; Luis M Amezcua-Guerra; Hector Gonzalez-Pacheco; Janette Furuzawa-Carballeda; Lorena Gomez-Garcia; Ricardo Marquez-Velasco; Ana María Mejía-Domínguez; Jorge Cossío-Aranda; Carlos Martínez-Sánchez; Rafael Bojalil
Journal:  PLoS One       Date:  2013-08-12       Impact factor: 3.240

5.  Plasma Long Non-Coding RNA (lncRNA) GAS5 is a New Biomarker for Coronary Artery Disease.

Authors:  Qiong Yin; Anshuang Wu; Manhua Liu
Journal:  Med Sci Monit       Date:  2017-12-21

6.  Complementary and alternative medicine use in coronary heart disease patients: a cross-sectional study from Palestine.

Authors:  Abdelraouf O Salah; Ahmad D Salameh; Mohanad A Bitar; Sa'ed H Zyoud; Abdulsalam S Alkaiyat; Samah W Al-Jabi
Journal:  BMC Complement Med Ther       Date:  2020-07-20

7.  Transforming Growth Factor β1 (TGF-β1) Appears to Promote Coronary Artery Disease by Upregulating Sphingosine Kinase 1 (SPHK1) and Further Upregulating Its Downstream TIMP-1.

Authors:  Shoudong Wang; Qing Zhang; Yingcui Wang; Beian You; Qingfeng Meng; Sen Zhang; Xuanlong Li; Zhiming Ge
Journal:  Med Sci Monit       Date:  2018-10-14

8.  The effect of informal caregiver support on utilization of acute health services among home care clients: a prospective observational study.

Authors:  Robert Abtan; Nooshin Khobzi Rotondi; Alison Macpherson; Michael Anthony Rotondi
Journal:  BMC Health Serv Res       Date:  2018-01-31       Impact factor: 2.655

9.  Association of GSTP1, GSTT1 and GSTM1 Gene Variants with Coronary Artery Disease in Iranian Population: A Case-Control Study.

Authors:  Alemeh Pourkeramati; Ehsan Zare Mehrjardi; Masoud Dehghan Tezerjani; Seyed Morteza Seifati
Journal:  Int J Gen Med       Date:  2020-05-28

10.  Integrative analysis of promising molecular biomarkers and pathways for coronary artery disease using WGCNA and MetaDE methods.

Authors:  Shilin Yan
Journal:  Mol Med Rep       Date:  2018-07-16       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.